X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Cadila Healthcare with GSK Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs GSK PHARMA - Comparison Results

CADILA HEALTHCARE    Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

GSK PHARMA 
   Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE GSK PHARMA CADILA HEALTHCARE/
GSK PHARMA
 
P/E (TTM) x 34.3 59.9 57.4% View Chart
P/BV x 8.8 11.7 75.3% View Chart
Dividend Yield % 0.7 2.1 32.9%  

Financials

 CADILA HEALTHCARE   GSK PHARMA
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-16
GSK PHARMA
Mar-16
CADILA HEALTHCARE/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs4543,850 11.8%   
Low Rs3052,966 10.3%   
Sales per share (Unadj.) Rs96.1332.3 28.9%  
Earnings per share (Unadj.) Rs14.944.3 33.6%  
Cash flow per share (Unadj.) Rs17.847.2 37.7%  
Dividends per share (Unadj.) Rs3.2050.00 6.4%  
Dividend yield (eoy) %0.81.5 57.5%  
Book value per share (Unadj.) Rs52.3202.7 25.8%  
Shares outstanding (eoy) m1,023.7484.70 1,208.7%   
Bonus/Rights/Conversions FV5:1--  
Price / Sales ratio x3.910.3 38.5%   
Avg P/E ratio x25.576.9 33.2%  
P/CF ratio (eoy) x21.372.2 29.5%  
Price / Book Value ratio x7.316.8 43.2%  
Dividend payout %21.5112.9 19.1%   
Avg Mkt Cap Rs m388,458288,643 134.6%   
No. of employees `00015.44.6 334.9%   
Total wages/salary Rs m13,3174,434 300.3%   
Avg. sales/employee Rs Th6,371.16,104.5 104.4%   
Avg. wages/employee Rs Th862.4961.6 89.7%   
Avg. net profit/employee Rs Th986.1813.7 121.2%   
INCOME DATA
Net Sales Rs m98,37628,148 349.5%  
Other income Rs m9411,218 77.2%   
Total revenues Rs m99,31729,366 338.2%   
Gross profit Rs m23,8294,774 499.2%  
Depreciation Rs m3,022248 1,218.5%   
Interest Rs m4860-   
Profit before tax Rs m21,2625,744 370.2%   
Minority Interest Rs m-3000-   
Prior Period Items Rs m50-   
Extraordinary Inc (Exp) Rs m-2526 -96.2%   
Tax Rs m5,7162,018 283.3%   
Profit after tax Rs m15,2263,752 405.8%  
Gross profit margin %24.217.0 142.8%  
Effective tax rate %26.935.1 76.5%   
Net profit margin %15.513.3 116.1%  
BALANCE SHEET DATA
Current assets Rs m44,37621,462 206.8%   
Current liabilities Rs m34,07110,536 323.4%   
Net working cap to sales %10.538.8 27.0%  
Current ratio x1.32.0 63.9%  
Inventory Days Days5468 79.6%  
Debtors Days Days6216 379.8%  
Net fixed assets Rs m47,8964,717 1,015.4%   
Share capital Rs m1,024847 120.9%   
"Free" reserves Rs m48,74616,308 298.9%   
Net worth Rs m53,51917,171 311.7%   
Long term debt Rs m8,96416 56,025.0%   
Total assets Rs m100,16330,620 327.1%  
Interest coverage x44.7NM-  
Debt to equity ratio x0.20 17,975.5%  
Sales to assets ratio x1.00.9 106.8%   
Return on assets %15.712.3 128.0%  
Return on equity %28.421.9 130.2%  
Return on capital %34.333.6 102.2%  
Exports to sales %45.30 318,580.4%   
Imports to sales %5.915.1 39.4%   
Exports (fob) Rs m44,5374 1,113,425.0%   
Imports (cif) Rs m5,8384,237 137.8%   
Fx inflow Rs m44,881519 8,647.6%   
Fx outflow Rs m9,0698,320 109.0%   
Net fx Rs m35,812-7,801 -459.1%   
CASH FLOW
From Operations Rs m19,9381,386 1,438.9%  
From Investments Rs m-9,0395,010 -180.4%  
From Financial Activity Rs m-9,527-6,383 149.2%  
Net Cashflow Rs m1,37212 11,627.1%  

Share Holding

Indian Promoters % 74.8 0.0 -  
Foreign collaborators % 0.0 50.7 -  
Indian inst/Mut Fund % 8.3 10.2 81.4%  
FIIs % 5.9 23.8 24.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 11.0 15.4 71.4%  
Shareholders   44,069 102,036 43.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   J.B.CHEMICALS  ALEMBIC LTD  WYETH LTD  JUBILANT LIFE SCIENCES  FRESENIUS KABI ONCO.  

Compare CADILA HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Bank & Realty Stocks Rally(Closing)

Indian share markets surged further in the afternoon session and finished in the green for the second straight session on heavy buying in realty stocks, metal stocks and bank stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Aug 23, 2017 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 8-QTR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS